IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation.
Journal article
Cao M. et al, (2023), Neurol Neuroimmunol Neuroinflamm, 10
Motor end-plate analysis to diagnose immune-mediated myasthenia gravis in seronegative patients.
Journal article
Nagaoka A. et al, (2022), J Neurol Sci, 443
Inhibition of Maternal-to-Fetal Transfer of IgG Antibodies by FcRn Blockade in a Mouse Model of Arthrogryposis Multiplex Congenita.
Journal article
Coutinho E. et al, (2021), Neurol Neuroimmunol Neuroinflamm, 8
Using AChR antibody titres to predict treatment responses in myasthenia gravis.
Journal article
Vincent A., (2021), J Neurol Neurosurg Psychiatry
Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis
Journal article
Pollak TA. et al, (2020), Molecular Psychiatry
Neuronal surface antibodies are common in children with narcolepsy and active movement disorders.
Journal article
Giannoccaro MP. et al, (2020), J Neurol Neurosurg Psychiatry
Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs.
Journal article
Cetin H. et al, (2020), J Neurol Neurosurg Psychiatry
SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody.
Journal article
Huda S. et al, (2020), Neurol Neuroimmunol Neuroinflamm, 7
Investigation of neuronal auto-antibodies in children diagnosed with epileptic encephalopathy of unknown cause.
Journal article
Tekturk P. et al, (2018), Brain Dev, 40, 909 - 917
Plasma cell depletion with bortezomib in the treatment of refractory N-methyl-d-aspartate (NMDA) receptor antibody encephalitis. Rational developments in neuroimmunological treatment.
Journal article
Keddie S. et al, (2018), Eur J Neurol, 25, 1384 - 1388
Antiglycine receptor antibody related disease: a case series and literature review.
Journal article
Swayne A. et al, (2018), Eur J Neurol, 25, 1290 - 1298
NMDA-receptor antibodies alter cortical microcircuit dynamics.
Journal article
Rosch RE. et al, (2018), Proceedings of the National Academy of Sciences of the United States of America, 115, E9916 - E9925
Passive Transfer of Human CASPR2 Antibodies into Mice Causes Behavioral and Neuropathological Changes
Conference paper
Giannoccaro MP. et al, (2018), ANNALS OF NEUROLOGY, 84, S137 - S137
Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia.
Journal article
Vincent A. et al, (2018), JAMA neurology
SHP2 INHIBITION BY NSC-87877 RECOVERS THE PATHOGENIC IN VITRO EFFECTS OF MUSK-MG ANTIBODY SUBCLASSES
Conference paper
Cao M. et al, (2018), MUSCLE & NERVE, 58, S15 - S16
Glutamate receptor delta2 serum antibodies in paediatric opsoclonus myoclonus ataxia syndrome
Journal article
Lang B. et al, (2018), Neurology
A passive transfer animal model of CASPR2 antibodies
Conference paper
Giannoccaro MP. et al, (2018), EUROPEAN JOURNAL OF NEUROLOGY, 25, 674 - 674
Brain-relevant antibodies in first-episode psychosis: a matched case-control study.
Journal article
Gaughran F. et al, (2018), Psychol Med, 48, 1257 - 1263
Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes.
Journal article
Cetin H. and Vincent A., (2018), Semin Neurol, 38, 344 - 354